China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Large Increase in Short Interest

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) saw a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 455,300 shares, a growth of 744.7% from the August 31st total of 53,900 shares. Currently, 13.1% of the company’s shares are short sold. Based on an average daily volume of 651,400 shares, the days-to-cover ratio is presently 0.7 days.

China SXT Pharmaceuticals Stock Down 3.3 %

Shares of NASDAQ:SXTC traded down $0.02 during midday trading on Wednesday, reaching $0.62. The company’s stock had a trading volume of 26,466 shares, compared to its average volume of 788,158. The company has a quick ratio of 1.51, a current ratio of 1.60 and a debt-to-equity ratio of 0.01. The firm has a 50 day moving average price of $0.87 and a two-hundred day moving average price of $1.13. China SXT Pharmaceuticals has a fifty-two week low of $0.53 and a fifty-two week high of $6.39.

About China SXT Pharmaceuticals

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.